Dean Banks

With “X” since 2016, he also serves on the board of Vergent Bioscience, which develops molecular imaging probes for life science R&D. He previously was managing partner of SEED Ventures, was a consultant to Cleveland Clinic Innovations, CEO of Occelerator, SVP of Business Development and Strategic Marketing at OrthoHelix, and was co-founder and CEO of Connective Orthopaedics.

  • 2018 First Quarter

Added to: Tyson Foods Inc. - Springdale, AR

Tyson is engaged in food production. Revenues are $43 billion.